Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Open-access clinic for arthralgia: patient flow and diagnostic pathways-a retrospective cohort study.

EULAR rheumatology open·2026
Same author

Continuous monitoring of blood-interstitial fluid intercompartmental molecular kinetics in freely moving animals.

Science advances·2026
Same author

Two-year follow-up of neuropsychiatric symptoms in patients with systemic autoimmune rheumatic diseases: longitudinal insights on depression, anxiety, memory and adaptation in the INSPIRE cohort.

EClinicalMedicine·2026
Same author

Formal and Informal Social Care in People With Rheumatic and Musculoskeletal Diseases: A Cross-Sectional Multicenter Survey.

Arthritis care & research·2026
Same author

Patient experiences of PMR: a qualitative narrative literature review.

Rheumatology advances in practice·2026
Same author

Polymyalgia rheumatica and giant cell arteritis: lumping versus splitting.

Rheumatology (Oxford, England)·2025
Same journal

Performance of an artificial intelligence model compared with multiple human experts in scoring synovitis and osteophyte severity on joint ultrasound images.

EULAR rheumatology open·2026
Same journal

Clinical features and management of LICATS involving the heart in a patient with diffuse and rapidly progressive systemic sclerosis.

EULAR rheumatology open·2026
Same journal

Opportunities and challenges of digital health in rheumatology according to patients and professionals: a cross-sectional study.

EULAR rheumatology open·2026
Same journal

Gender disparity in rheumatology clinical guidelines: "rheum" for improvement?

EULAR rheumatology open·2026
Same journal

Examining emergency department utilisation in people with Crystal Arthropathies: a 10-year analysis of visits in a publicly funded universal healthcare system.

EULAR rheumatology open·2026
Same journal

Standardised multidisciplinary rehabilitation improves health-related quality of life and productivity costs in patients with rheumatic, musculoskeletal and other diseases.

EULAR rheumatology open·2026
See all related articles

Related Experiment Video

Updated: Jun 30, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Rapid access strategies for polymyalgia rheumatica: current knowledge.

Elisabeth L Nielsen1, Alex J MacGregor2, Max Yates2

  • 1Aarhus University, Aarhus, Denmark.

EULAR Rheumatology Open
|June 29, 2026
PubMed
Summary
This summary is machine-generated.

Rapid access strategy (RAS) clinics show promise for diagnosing polymyalgia rheumatica (PMR), but inconsistent logistics hinder widespread adoption. Further research is needed to establish evidence-based care pathways for effective PMR management.

Related Experiment Videos

Last Updated: Jun 30, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Area of Science:

  • Rheumatology
  • Clinical Practice
  • Health Services Research

Background:

  • Polymyalgia rheumatica (PMR) diagnosis is challenging in primary care due to lack of definitive tests and overlapping symptoms.
  • Rapid access strategy (RAS) clinics are used for giant cell arteritis but their effectiveness for PMR is unproven.

Purpose of the Study:

  • To review current evidence on the logistics of RAS clinics for polymyalgia rheumatica (PMR).
  • To inform the development of future RAS PMR clinics.

Main Methods:

  • A systematic review of studies on RAS PMR clinics was conducted.
  • Data extraction focused on clinic logistics, referral criteria, diagnostic assessments, and treatment outcomes.

Main Results:

  • Four studies on RAS PMR clinics were included, reporting referral numbers and diagnostic assessments.
  • PMR diagnosis rates ranged from 59% to 73%; however, logistics, glucocorticoid initiation, and follow-up were inconsistently reported.
  • A higher proportion of males than expected was observed.

Conclusions:

  • RAS PMR clinics may enhance diagnostic accuracy and reduce unnecessary glucocorticoid use.
  • Underreported logistics and selection bias limit generalizability; cost-effectiveness was not assessed.
  • Development of scalable, evidence-based care pathways is crucial before broader implementation.